CAQ-Nephrology study materials
CAQ-Nephrology study resources

CAQ-Nephrology: Glomerular and Tubulointerstitial Disease

CAQ-Nephrology ยท Work through your exam, one topic at a time.

All guide sections

Glomerular and Tubulointerstitial Disease

Glomerular and Tubulointerstitial Disease

This domain tests pattern recognition: separating nephritic from nephrotic syndromes, linking serology and biopsy findings to a diagnosis, and choosing initial management. Expect questions on complement levels, immunofluorescence patterns, and drug-induced tubulointerstitial disease.

Core rules

  • Nephritic syndrome: hematuria with dysmorphic RBCs and RBC casts, hypertension, oliguria, and falling GFR. Nephrotic syndrome: proteinuria >3.5 g/day, hypoalbuminemia, edema, hyperlipidemia, and lipiduria.
  • IgA nephropathy causes synpharyngitic gross hematuria 1โ€“2 days after a URI with normal complement and mesangial IgA deposits. Post-infectious GN follows 1โ€“3 weeks after strep infection with low C3 and subepithelial humps.
  • Anti-GBM disease gives linear IgG on immunofluorescence; ANCA vasculitis is pauci-immune; membranous nephropathy shows subepithelial spikes and anti-PLA2R antibodies.
  • Minimal change disease shows podocyte effacement and is steroid-responsive; FSGS shows segmental sclerosis. MPGN often has low C3 and tram-track appearance.
  • Acute interstitial nephritis: drugs such as NSAIDs, antibiotics, and PPIs; fever, rash, eosinophilia, WBC casts, and eosinophiluria; stop the drug and consider steroids.

Worked example

A 28-year-old develops gross hematuria two days after a sore throat. Complement C3 is normal. Biopsy shows mesangial IgA deposits. The timing and normal complement point to IgA nephropathy, not post-infectious GN, which typically has a latent period and low C3. Management is supportive; ACE inhibitors reduce proteinuria in persistent disease.

Traps

  • Calling RBC casts a lower urinary tract finding; they indicate glomerular bleeding.
  • Forgetting that complement levels narrow the differential.
  • Treating rapidly progressive GN before biopsy confirmation.
  • Missing drug-induced AIN because fever and rash are absent.